The UHM Vacation IPO GMP (Grey Market Premium) has started in the grey market, along…
Bio Medica Laboratories IPO GMP Day-2: Grey Market Premium
Track the latest Bio Medica Laboratories IPO GMP, including Grey Market Premium, Kostak rates, and Subject to Sauda updates for today. The Bio Medica Laboratories IPO GMP has started showing movement in the grey market, and investors are closely monitoring the latest trends ahead of the IPO process. Stay tuned for regular updates on Bio Medica Laboratories IPO GMP and grey market activity.
Bio Medica Laboratories IPO GMP touched a high of ₹3.5 on 22nd May, while the lowest GMP recorded was ₹0 on 21st May. The Bio Medica Laboratories IPO is set to open on May 21, 2026. It is an SME IPO that aims to raise around ₹52.43 crores. The IPO price band is fixed at ₹132 to ₹139 per share with a market lot of 2,000 shares.
| Date | IPO GMP | GMP Trend | Gain |
|---|---|---|---|
| 20 May | ₹- | – | -% |
| 19 May | ₹- | – | -% |
| 18 May | ₹- | – | -% |
| 16 May | ₹- | – | -% |
| 15 May | ₹- | – | -% |
| 14 May | ₹- | – | -% |
| 13 May | ₹- | – | -% |
About Company
BIO MEDICA LABORATORIES LIMITED is a leading parenteral manufacturing company based in Central India, known for its strong focus on quality, innovation, and healthcare excellence. The company specializes in producing a wide range of parenteral formulations, including injectables for human and veterinary applications. Built on a foundation of Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP), BIO MEDICA ensures that every product meets strict international standards of safety, purity, and effectiveness. Its modern manufacturing facilities are equipped with advanced technology, enabling consistent production of high-quality injectable solutions for domestic as well as global markets.
The company offers a diverse portfolio of injectable products designed to meet the needs of hospitals, healthcare providers, and veterinary care sectors. With a growing export presence, BIO MEDICA LABORATORIES LIMITED continues to expand its global footprint by delivering reliable healthcare solutions worldwide. The organization is driven by a strong mission to improve health and well-being through innovative parenteral formulations for both humans and animals. Its vision is to become a globally recognized leader in the pharmaceutical manufacturing industry by maintaining excellence, sustainability, and continuous improvement in all aspects of its operations.
Related Posts
